Effectiveness and Safety of Factor Xa Inhibitors in Patients with Atrial Fibrillation -...
Oct 1, 2019 - Treatment of AFib with a factor Xa inhibitor results in a decrease in the combined end point of stroke and embolic events (odds ratio [OR] = 0.89; 95% CI, 0.82 to 0.97), as well as a decrease in intracranial hemorrhage (OR = 0.50; 95% CI, 0.42 to 0.59) and all-cause mortality (OR = ...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2019/1001/p405.html
Oral Anticoagulants vs. Antiplatelet Therapy - Cochrane for Clinicians - American ...
May 1, 2008 - Compared with antiplatelet therapy, oral anticoagulation significantly reduces stroke at an average follow-up of one to three years, but does not reduce mortality. Intracranial or extracranial hemorrhage is more common with anticoagulation and must be weighed against its therapeutic ...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2008/0501/p1250.html
Pharmacologic Cardioversion for Atrial Fibrillation and Flutter - Cochrane for ...
Dec 1, 2005 - There is no evidence that rhythm control in older patients with atrial fibrillation is more effective than rate control for improving patient-oriented outcomes.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2005/1201/p2217.html
navigate_before 1 navigate_next